|
|
News Breaks | | | | September 28, 2012 | | 05:53 EDT |  | BSX | Boston Scientific launches Vercise deep brain stimulation system in Europe
Boston Scientific received CE Mark approval for use of its Vercise Deep Brain Stimulation, or DBS, system for the treatment of Parkinson's disease. The Vercise DBS System is the first and only commercially available DBS system to incorporate multiple independent current control, which is designed to selectively stimulate targeted areas in the brain. This system is an innovative technology that is designed to provide physicians fine control of stimulation. | |
|
News For BSX From The Last 14 Days Check below for free stories on BSX the last two weeks. |
|
|
| June 18, 2013 | | 05:23 EDT | | BSX | Boston Scientific Vercise DBS System demonstrates improvement in motor function
Patients with Parkinson's disease using the Boston Scientific Vercise DBS, or deep brain stimulation, System showed a significant improvement in motor scores according to interim data from the VANTAGE DBS study. The Vercise DBS System incorporates multiple independent current control, which is designed to selectively stimulate targeted areas in the brain, providing physicians with fine control of stimulation. Preliminary analysis of the VANTAGE study displays approximately 60% mean improvement in motor function at six months post implant, as assessed by UPDRS III when compared to baseline. | | | June 17, 2013 | | 17:04 EDT | | BSX | Boston Scientific begins patient enrollment in U.S. clinical trial for Vercise
 Subscribe for More Information | |
|
|
|
|
|
|
